Kura Oncology (KURA) EBITDA (2010 - 2026)
Kura Oncology's (KURA) quarterly EBITDA came in at -$78.8 million in Q1 2026, down 21.82% year-on-year from -$100.8 million in Q1 2025, and up 2.19% on a QoQ basis from -$80.6 million in Q4 2025.
Kura Oncology (KURA) EBITDA (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 8 years of EBITDA data on file, last reported at -$78.8 million in Q1 2026.
- On a quarterly basis, EBITDA fell 21.82% year-over-year to -$78.8 million in Q1 2026; TTM through Mar 2026 was -$274.1 million, a 1865.48% decrease from a year earlier, with the FY2025 full-year figure at -$303.6 million, down 57.16% from the prior year.
- EBITDA for Q1 2026 stood at -$78.8 million, up from -$80.6 million in the prior quarter.
- Over the last five years, EBITDA for KURA reached as high as $155.1 million in Q4 2024 and fell as low as -$80.6 million in Q4 2025.
- Historically, EBITDA has averaged -$37.4 million across 3 years, with a median of -$54.0 million in 2024.
- On a YoY basis, EBITDA climbed as much as 18.44% in 2025 and fell as far as 151.96% in 2025.
- Year by year, EBITDA stood at $155.1 million in 2024, then tumbled by 151.96% to -$80.6 million in 2025, then climbed by 2.19% to -$78.8 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$78.8 million in Q1 2026, -$80.6 million in Q4 2025, and -$73.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Kura Oncology | 925.97 Mn | 925.97 Mn | 18.00 Mn | -78.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.82 Mn |
| Dec 31, 2025 | -80.58 Mn |
| Sep 30, 2025 | -73.62 Mn |
| Jun 30, 2025 | -41.05 Mn |
| Mar 31, 2025 | -64.70 Mn |
| Dec 31, 2024 | 155.09 Mn |
| Sep 30, 2024 | -53.99 Mn |
| Jun 30, 2024 | -50.34 Mn |
| Mar 31, 2024 | -49.03 Mn |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,764.00 |
| Jun 30, 2014 | -5,242.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,716.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,728.00 |
| Jun 30, 2012 | -4,996.00 |